| [1] |
Torre LA, Bray F, Siegel RL, et al. Global cancer statistics, 2012[J]. CA Cancer J Clin, 2015, 65(2):87-108.
|
| [2] |
Brenner H, Kloor M, Pox CP.Colorectal cancer[J]. Lancet, 2014, 383(9927):1490-1502.
|
| [3] |
Fedirko V, Romieu I, Aleksandrova K, et al. Pre-diagnostic anthropometry and survival after colorectal cancer diagnosis in Western European populations[J]. Int J Cancer , 2014, 135(8):1949-1960.
|
| [4] |
Zheng R, Zeng H, Zhang S, et al. National estimates of cancer prevalence in China, 2011[J]. Cancer Lett, 2015, 13(15):620-625.
|
| [5] |
Kattan MW, Gonen M, Jarnagin WR, et al. A nomogram for predicting disease-specific survival after hepatic resection for metastatic colorectal cancer[J]. Ann Surg, 2008, 247(2):282-287.
|
| [6] |
Arru M, Aldrighetti L, Castoldi R, et al. Analysis of prognostic factors influencing long-term survival after hepatic resection for metastatic colorectal cancer[J]. World J Surg, 2008, 32(1):93-103.
|
| [7] |
Mineo TC, Ambrogi V, Tonini G, et al. Longterm results after resection of simultaneous and sequential lung and liver metastases from colorectal carcinoma[J]. J Am Coll Surg, 2003, 197(3):386-391.
|
| [8] |
Fong Y, Cohen AM, Fortner JG, et al. Liver resection for colorectal metastases[J]. J Clin Oncol , 1997, 15(3):938-946.
|
| [9] |
Barlow AD, Nakas A, Pattenden C, et al. Surgical treatment of combined hepatic and pulmonary colorectal cancer metastases[J]. Eur J Surg Oncol, 2009, 35(3):307-312.
|
| [10] |
Fong Y, Fortner J, Sun RL, et al. Clinical score for predicting recurrence after hepatic resection for metastatic colorectal cancer: analysis of 1001 consecutive cases[J]. Ann Surg, 1999, 230(3):309-318.
|
| [11] |
Simmonds PC, Primrose JN, Colquitt JL, et al. Surgical resection of hepatic metastases from colorectal cancer: a systematic review of published studies[J]. Br J Cancer, 2006, 94(7):982-999.
|
| [12] |
Charnsangavej C, Clary B, Fong Y, et al. Selection of patients for resection of hepatic colorectal metastases: expert consensus statement[J]. Ann Surg Oncol, 2006, 13(10):1261-1268.
|
| [13] |
Gallinger S, Biagi JJ, Fletcher GG, et al. Liver resection for colorectal cancer metastases[J]. Curr Oncol, 2013, 20(3):e255-265.
|
| [14] |
Bismuth H, Adam R, Levi F, et al. Resection of nonresectable liver metastases from colorectal cancer after neoadjuvant chemotherapy[J]. Ann Surg, 1996, 224(4):509-520.
|
| [15] |
Benoist S, Nordlinger B.The role of preoperative chemotherapy in patients with resectable colorectal liver metastases[J]. Ann Surg Oncol, 2009, 16(9):2385-2390.
|
| [16] |
Sahajpal A, Vollmer CM, Dixon E, et al. Chemotherapy for colorectal cancer prior to liver resection for colorectal cancer hepatic metastases does not adversely affect peri-operative outcomes[J]. J Surg Oncol, 2007, 95(1):22-27.
|
| [17] |
Adam R, Wicherts DA, de Haas RJ, et al. Complete pathologic response after preoperative chemotherapy for colorectal liver metastases: myth or reality[J]? J Clin Oncol, 2008, 26(10):1635-1641.
|
| [18] |
Khatri VP, Petrelli NJ, Belghiti J.Extending the frontiers of surgical therapy for hepatic colorectal metastases: is there a limit[J]? J Clin Oncol, 2005, 23(33):8490-8499.
|
| [19] |
Pawlik TM, Schulick RD, Choti MA.Expanding criteria for resectability of colorectal liver metastases[J]. Oncologist , 2008, 13(1):51-64.
|
| [20] |
McCormack PM, Attiyeh FF.Resected pulmonary metastases from colorectal cancer[J]. Dis Colon Rectum, 1979, 22(8):553-556.
|
| [21] |
Koppe MJ, Boerman OC, Oyen WJ, et al. Peritoneal carcinomatosis of colorectal origin: incidence and current treatment strategies[J]. Ann Surg, 2006, 243(2):212-222.
|
| [22] |
Iizasa T, Suzuki M, Yoshida S, et al. Prediction of prognosis and surgical indications for pulmonary metastasectomy from colorectal cancer[J]. Ann Thorac Surg, 2006, 82(1):254-260.
|
| [23] |
Irshad K, Ahmad F, Morin JE, et al. Pulmonary metastases from colorectal cancer: 25 years of experience[J]. Can J Surg, 2001, 44(3):217-221.
|
| [24] |
Saito Y, Omiya H, Kohno K, et al. Pulmonary metastasectomy for 165 patients with colorectal carcinoma: A prognostic assessment[J]. J Thorac Cardiovasc Surg, 2002, 124(5):1007-1013.
|
| [25] |
Welter S, Jacobs J, Krbek T, et al. Prognostic impact of lymph node involvement in pulmonary metastases from colorectal cancer[J]. Eur J Cardiothorac Surg, 2007, 31(2):167-172.
|
| [26] |
Kawano D, Takeo S, Tsukamoto S, et al. Prediction of the prognosis and surgical indications for pulmonary metastectomy from colorectal carcinoma in patients with combined hepatic metastases[J]. Lung Cancer, 2012, 75(2):209-212.
|
| [27] |
Rena O, Casadio C, Viano F, et al. Pulmonary resection for metastases from colorectal cancer: factors influencing prognosis. Twenty-year experience[J]. Eur J Cardiothorac Surg, 2002, 21(5):906-912.
|
| [28] |
Hiraki T, Gobara H, Iguchi T, et al. Radiofrequency ablation as treatment for pulmonary metastasis of colorectal cancer[J]. World J Gastroenterol, 2014, 20(4):988-996.
|
| [29] |
王锡山.结直肠癌联合脏器切除得与失及临床病理分期的思考[J]. 中国实用外科杂志, 2010, 30(12):1002-1004.
|
| [30] |
潘义生，万远廉，刘玉村, 等. 全盆腔脏器切除术治疗直肠癌术后盆腔局部复发[J]. 中华普通外科杂志, 2005, 20(6):329-331.
|
| [31] |
万远廉，徐文怀，陈如法, 等.全盆腔脏器切除术治疗局部进展期直肠癌[J]. 中华外科杂志, 1995, 33(8):458-460.
|
| [32] |
Pan YS, Wan YL, Liu YC, et al. Outcome of total pelvic exenteration for local advanced primary and recurrent rectal cancer[J]. China Journal of Modern Medicine, 2005, 15(3):332-339.
|
| [33] |
万远廉，徐文怀，陈如法, 等.全盆腔脏器切除术治疗局部进展期盆腔恶性肿瘤[J]. 北京医科大学学报, 1995, 27(6):450-452.
|
| [34] |
万远廉，潘义生，刘玉村, 等.中下段直肠癌盆腔侧方淋巴转移情况与转归[J]. 中华胃肠外科杂志, 2004(02):104-106.
|
| [35] |
万远廉，潘义生，刘玉村, 等. 462例中下段直肠癌淋巴转移规律与淋巴清扫范围的分析[J]. 中华外科杂志, 2001(06):12-15.
|
| [36] |
赵运平.局部晚期/复发性直肠癌患者根治性全盆腔脏器切除术的疗效[J]. 中国临床研究, 2015(05):595-597.
|
| [37] |
Toda S, Kuroyanagi H.Laparoscopic surgery for rectal cancer: current status and future perspective[J]. Asian J Endosc Surg , 2014, 7(1):2-10.
|
| [38] |
Jayne DG, Fook S, Loi C, et al. Peritoneal carcinomatosis from colorectal cancer[J]. Br J Surg, 2002, 89(12):1545-1550.
|
| [39] |
Cunningham D, Humblet Y, Siena S, et al. Cetuximab monotherapy and cetuximab plus irinotecan in irinotecan-refractory metastatic colorectal cancer[J]. N Engl J Med, 2004, 351(4):337-345.
|